Notice of Annual Meeting and Voting Form

Auckland, New Zealand, 7 July 2021 - Fisher & Paykel Healthcare Corporation Limited has provided a copy of the Notice of Meeting for its 2021 Annual Shareholders’ Meeting, which will be held online at and at the Newmarket Room, Ellerslie Event Centre, Auckland, New Zealand on Wednesday, 18 August 2021 at 2.00pm (NZST).

Fisher & Paykel Healthcare is closely monitoring the situation in New Zealand with regard to COVID-19. In the event of any significant developments, the company may, at its discretion, elect to hold the Annual Shareholders’ Meeting as an online-only meeting if there are potential risks to the health of meeting attendees, or if an in-person meeting is prohibited by law. In such circumstances, the company will provide shareholders with as much notice as is reasonably practicable by way of an announcement to the NZX and ASX and on our website at

COVID-19-related safety precautions will be in place at the in-person meeting, including mandatory masks and physical distancing. Attendees will be required to register their presence by signing in or using the New Zealand Government COVID-19 contact tracing application. These extra measures are consistent with the company’s current on-site health and safety protocols at its New Zealand campus.

The Notice of Meeting and Voting Form will be emailed to shareholders who have provided the company’s share registrar with an email address and mailed in hard copy where the company’s share registrar does not have an email address. An electronic copy of these documents will also be available on the company’s website,


About Fisher & Paykel Healthcare

Fisher & Paykel Fisher Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in more than 120 countries worldwide. For more information about the company, visit our website






Hayden Brown
Investor Relations Manager
+64 (0) 27 807 8073



Karen Knott
GM – Corporate Communications
+64 (0) 21 713 911